• Back to miR-423-5p

• Rizzacasa, Barbara, et al. "MiR-423 is differentially expressed in patients with stable and unstable coronary artery disease: A pilot study." PloS one 14.5 (2019): e0216363.
• Li, Shouwei, et al. "miR-423-5p contributes to a malignant phenotype and temozolomide chemoresistance in glioblastomas." Neuro-oncology 19.1 (2016): 55-65.
• Liu, Jingjing, et al. "miRNA423-5p regulates cell proliferation and invasion by targeting trefoil factor 1 in gastric cancer cells." Cancer letters 347.1 (2014): 98-104.
• Lin, Haili, et al. "Inhibition of miR-423-5p suppressed prostate cancer through targeting GRIM-19." Gene 688 (2019): 93-97.
• Tang, Xuebiao, et al. "miR 423 5p serves as a diagnostic indicator and inhibits the proliferation and invasion of ovarian cancer." Experimental and therapeutic medicine 15.6 (2018): 4723-4730.
• Wang, Xuesong, et al. "miR-423-5p inhibits osteosarcoma proliferation and invasion through directly targeting STMN1." Cellular Physiology and Biochemistry 50.6 (2018): 2249-2259.
• Tijsen, Anke J., et al. "MiR423-5p as a circulating biomarker for heart failure." Circulation research 106.6 (2010): 1035.
• Miyamoto, Shoichi, et al. "Expression patterns of miRNA-423-5p in the serum and pericardial fluid in patients undergoing cardiac surgery." PloS one 10.11 (2015): e0142904.
• Guo, Li, et al. "MicroRNA-423–5p inhibits the progression of trophoblast cells via targeting IGF2BP1." Placenta 74 (2018): 1-8.
• Yang, Weili, et al. "NFE2 induces miR-423-5p to promote gluconeogenesis and hyperglycemia by repressing the hepatic FAM3A-ATP-Akt pathway." Diabetes 66.7 (2017): 1819-1832.
• Tu, Huihui, et al. "Elevated pulmonary tuberculosis biomarker miR-423-5p plays critical role in the occurrence of active TB by inhibiting autophagosome-lysosome fusion." Emerging microbes & infections 8.1 (2019): 448-460.